Scharf Global Opportunity ETF (GKAT) Valuation
GKAT valuation today
Holdings combined · company data as of Oct 26, 2026- P/E (TTM)
- 20.8 trailing earnings
- Forward P/E
- 13.5 analyst estimates
- Price / sales
- 0.04
- Price / book
- 2.59
- EV / EBITDA
- 11.4
- Earnings yield
- 4.80% inverse of P/E
- Dividend yield
- 1.41% of the holdings
- Return on equity
- 12.4% combined
- Net margin
- 0.2% combined
- Beta
- 0.73 weighted, vs S&P 500
GKAT valuation vs other stock ETFs
| ETF | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE | Net margin | Loss-makers |
|---|---|---|---|---|---|---|---|---|
| GKAT | 20.8 | 13.5 | 0.04 | 2.59 | 1.41% | 12.4% | 0.2% | 2.3% |
| SPY | 25.9 | 19.9 | 3.67 | 5.47 | 1.08% | 21.1% | 14.2% | 1.9% |
| QQQ | 34.2 | 23.4 | 5.93 | 9.27 | 0.58% | 27.1% | 17.4% | 6.9% |
| DIA | 20.9 | 18.4 | 3.16 | 5.52 | 1.55% | 26.4% | 15.1% | 0.0% |
| VTI | 28.2 | 19.4 | 3.31 | 5.00 | 1.07% | 17.7% | 11.8% | 4.6% |
| IWM | n/m | 13.9 | 1.25 | 2.03 | 1.38% | −1.7% | −1.0% | 28.1% |
Same method for every fund. n/m = not meaningful (combined trailing earnings below zero or close to it). Loss-makers = weight of holdings with negative trailing earnings.
GKAT valuation by sector
| Sector | Weight | P/E | Fwd P/E | P/S | P/B | Div. yield | ROE |
|---|---|---|---|---|---|---|---|
| Healthcare | 27.9% | 30.9 | 14.9 | 0.72 | 3.70 | 1.75% | 12.0% |
| Financial Services | 22.6% | 15.3 | 12.0 | 0.01 | 1.90 | 1.23% | 12.4% |
| Technology | 17.1% | 15.1 | 10.5 | 2.71 | 2.31 | 0.60% | 15.3% |
| Industrials | 8.8% | 27.7 | 20.9 | 2.79 | 3.89 | 1.72% | 14.1% |
| Energy | 2.8% | 17.7 | 14.6 | 2.61 | 1.68 | 1.80% | 9.5% |
| Communication Services | 2.8% | 22.8 | 13.8 | 1.93 | 1.62 | 1.36% | 7.1% |
GKAT earnings yield vs bond yields
Earnings yield = earnings ÷ price (1 ÷ P/E). The gap to bond yields is a rough gauge of the extra return stocks are priced to deliver.
How GKAT weight splits by P/E
Share of the covered weight in companies with a trailing P/E in each range.
GKAT largest holdings: valuation
| Symbol | Company | Weight | P/E | Fwd P/E | P/S | Div. yield | Share of earnings |
|---|---|---|---|---|---|---|---|
| K7X | BROOKFIELD CORP. CL.A | 6.12% | — | — | — | — | — |
| FNV | Franco-Nevada Corporation | 4.76% | — | — | — | — | — |
| MCK | McKesson Corporation | 4.68% | 26.9 | 19.7 | 0.3 | 0.37% | 5.31% |
| SSNLF | Samsung Electronics Co Ltd | 4.21% | — | — | — | — | — |
| NVS | Novartis AG | 4.16% | 22.8 | 14.7 | 5.0 | 3.15% | 5.59% |
| MSFT | Microsoft Corporation | 3.88% | 29.5 | 25.1 | 11.8 | 0.74% | 4.03% |
| UNP | Union Pacific Corporation | 3.87% | 23.4 | 19.3 | 6.8 | 1.97% | 5.04% |
| AZN | AstraZeneca PLC | 3.84% | 23.8 | 14.6 | 4.2 | 1.94% | 4.94% |
| FISV | Fiserv, Inc. | 3.66% | 9.1 | 5.7 | 1.2 | — | 12.25% |
| HEINY | Heineken NV | 3.60% | — | — | — | — | — |
| H6D | Haleon PLC | 3.22% | — | — | — | — | — |
| BRK.B | Berkshire Hathaway Inc. | 3.00% | 13.4 | 22.7 | 3.0 | — | 6.85% |
| CB | Chubb Limited | 2.89% | 12.7 | 11.6 | 2.2 | 1.13% | 6.93% |
| CME | CME Group Inc. | 2.83% | 24.9 | 21.9 | 15.6 | 1.77% | 3.47% |
| OXY | Occidental Petroleum Corporation | 2.79% | 17.7 | 14.6 | 2.6 | 1.80% | 4.82% |
| ZTS | Zoetis Inc. | 2.77% | 13.1 | 12.0 | 3.4 | 2.67% | 6.48% |
| DIS | The Walt Disney Company | 2.77% | 22.8 | 13.8 | 1.9 | 1.36% | 3.71% |
| MKL | Markel Corporation | 2.75% | 10.2 | 15.2 | 1.4 | — | 8.26% |
| ORCL | Oracle Corporation | 2.64% | 20.1 | 17.8 | 5.4 | 1.56% | 4.02% |
| SNE | Sony Corporation | 2.49% | — | — | — | — | — |
| SNN | Smith & Nephew plc | 2.23% | 19.8 | 11.2 | 1.9 | 2.73% | 3.45% |
| A | Agilent Technologies, Inc. | 2.08% | 34.1 | 23.9 | 6.6 | 0.59% | 1.86% |
| UNH | UnitedHealth Group Incorporated | 2.05% | 25.8 | 16.6 | 0.8 | 2.31% | 2.42% |
| OTIS | Otis Worldwide Corporation | 1.88% | 18.3 | 15.1 | 1.8 | 2.47% | 3.14% |
| TMO | Thermo Fisher Scientific Inc. | 1.84% | 37.1 | 24.2 | 5.5 | 0.27% | 1.52% |
Share of earnings = the holding's part of the fund's combined trailing profit. Green: earns more than its weight; orange: less. Symbol links go to each company's key metrics.
About GKAT valuation
Adding up its 27 holdings with company data, GKAT trades at 20.8 times trailing earnings and 13.5 times analysts' forward estimates, with a price-to-book ratio of 2.59 and a dividend yield of 1.41%. Its earnings yield of 4.80% is 0.53 percentage points below the 5.33% yield to maturity of the U.S. bond market (AGG).
The ten largest holdings are 42.8% of the fund and earn 59.2% of its combined profit. By sector, Healthcare is the most expensive at 30.9 times earnings and Technology the cheapest at 15.1. Companies that lost money over the past year are 2.3% of the covered weight.
How these figures are calculated. Each ratio treats the fund as one company: the earnings, sales and book value of every holding are added up in proportion to its weight and divided into the fund's price. In practice that is a weighted harmonic mean, so a single stock with a very high P/E cannot distort the result, and loss-making companies reduce the fund's earnings instead of being dropped. Covers 68.6% of the fund's weight (U.S.-listed stocks with company data); company figures as of October 26, 2026.
Related: GKAT chart, GKAT performance, GKAT holdings, GKAT dividends.
GKAT valuation FAQ
What is the P/E ratio of GKAT?
Based on its holdings, GKAT has a trailing P/E of 20.8 and a forward P/E of 13.5 (earnings of all covered holdings combined in proportion to their weights, as of October 26, 2026).
What is the earnings yield of GKAT?
The trailing earnings yield is 4.80% (1 ÷ P/E) and the forward earnings yield 7.39%. For comparison the U.S. bond market (AGG) yields 5.33% to maturity and T-bills about 3.91%.
Is GKAT more expensive than the S&P 500?
GKAT trades at 20.8 times trailing earnings versus 25.9 for the S&P 500 (SPY); on forward estimates the figures are 13.5 and 19.9.
What is the price-to-book ratio of GKAT?
The holdings of GKAT trade at 2.59 times book value, with a combined return on equity of 12.4%.
Which sector in GKAT has the highest P/E?
Healthcare has the highest P/E at 30.9 and Technology the lowest at 15.1.